Dr. Reddy’s (NYSE:RDY) on Thursday announced a licensing agreement with China-based Shanghai Henlius Biotech (OTCPK:SGBCF) to jointly develop and market a biosimilar version of Darzalex, a multiple ...
The panelist discusses how for managing patients with R/R multiple myeloma, community clinicians should focus on personalized ...
The Connect MM Registry is the longest-running and largest registry in the US, providing invaluable prognostic insights into ...
Days after the European Commission (EC) granted approval, the UK’s Medicines and Healthcare Regulatory Agency (MHRA) has ...
For four decades, Ohio State blood and bone marrow transplant innovation has improved cancer care with an increasing emphasis ...
In this video interview, Michael Andreini, president and CEO of the Multiple Myeloma Research Foundation, highlights how the ...
Cendakimab fell short of the bar. The antibody hits IL-13, one of the interleukins targeted by Regeneron and Sanofi’s ...
More Than 20 Alpha Therapies Are In Clinical Trials Says KUICK RESEARCH In Recent PublicationDelhi, Jan. 29, 2025 (GLOBE ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback